Dendritic Cells in Human Lung Disease: Recent Advances

Chest

Volumn 151, Issue 3, 2017, Pages 668-673

  Upham, John W ^a,b   Xi, Yang ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

dendritic cells; immune regulation

Indexed keywords

ALPHA INTERFERON; ANTIGEN; B7 ANTIGEN; CD103 ANTIGEN; CD11B ANTIGEN; CD141 ANTIGEN; CD1C ANTIGEN; CD276 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; FC RECEPTOR; GAMMA INTERFERON; GRANZYME B; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN E RECEPTOR ALPHA CHAIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 25 RECEPTOR; INTERLEUKIN 33; INTERLEUKIN 8; PROGRAMMED DEATH 1 LIGAND 1; T6 ANTIGEN; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ASTHMA; CANCER GROWTH; CANCER PROGNOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SUBPOPULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; HOSPITALIZATION; HUMAN; IMMUNOLOGICAL TOLERANCE; LUNG LAVAGE; MYELOID DENDRITIC CELL; NON SMALL CELL LUNG CANCER; NONHUMAN; OBSERVATIONAL STUDY; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; PLEURA MESOTHELIOMA; PREVOTELLA; PROSPECTIVE STUDY; REVIEW; T LYMPHOCYTE ACTIVATION; TH17 CELL; TH2 CELL; VEILLONELLA; DENDRITIC CELL; IMMUNOLOGY; LUNG; LUNG DISEASE; LUNG TUMOR; MESOTHELIOMA; MICROBIOLOGY; MICROFLORA; PNEUMONIA; T LYMPHOCYTE;

ASTHMA; DENDRITIC CELLS; HUMANS; LUNG; LUNG DISEASES; LUNG NEOPLASMS; MESOTHELIOMA; MICROBIOTA; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; T-LYMPHOCYTES;

EID: 85014535396     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.09.030     Document Type: Review

References (56)

1. 1 Duan, W., Croft, M., Control of regulatory T cells and airway tolerance by lung macrophages and dendritic cells. Ann Am Thorac Soc 11 suppl 5 (2014), S306–S313.
2. 2 Guilliams, M., Lambrecht, B.N., Hammad, H., Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal Immunol 6:3 (2013), 464–473.
3. 3 Kopf, M., Schneider, C., Nobs, S.P., The development and function of lung-resident macrophages and dendritic cells. Nat Immunol 16:1 (2015), 36–44.
4. 4 Porter, M., Karp, M., Killedar, S., et al. Diesel-enriched particulate matter functionally activates human dendritic cells. Am J Respir Cell Mol Biol 37:6 (2007), 706–719.
5. 5 Bleck, B., Tse, D.B., Gordon, T., Ahsan, M.R., Reibman, J., Diesel exhaust particle-treated human bronchial epithelial cells upregulate Jagged-1 and OX40 ligand in myeloid dendritic cells via thymic stromal lymphopoietin. J Immunol 185:11 (2010), 6636–6645.
6. 6 Desch, A.N., Gibbings, S.L., Goyal, R., et al. Flow cytometric analysis of mononuclear phagocytes in nondiseased human lung and lung-draining lymph nodes. Am J Respir Crit Care Med 193:6 (2016), 614–626.
7. 7 Lynch, J.P., Mazzone, S.B., Rogers, M.J., et al. The plasmacytoid dendritic cell: at the cross-roads in asthma. Eur Respir J 43:1 (2014), 264–275.
8. 8 Ito, T., Kanzler, H., Duramad, O., Cao, W., Liu, Y.J., Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107:6 (2006), 2423–2431.
9. 9 Fitzgerald-Bocarsly, P., Dai, J., Singh, S., Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 19:1 (2008), 3–19.
10. 10 de Heer, H.J., Hammad, H., Soullie, T., et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 200:1 (2004), 89–98.
11. 11 Lombardi, V., Speak, A.O., Kerzerho, J., Szely, N., Akbari, O., CD8alpha(+)beta(-) and CD8alpha(+)beta(+) plasmacytoid dendritic cells induce Foxp3(+) regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal Immunol 5:4 (2012), 432–443.
12. 12 Smit, J.J., Rudd, B.D., Lukacs, N.W., Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 203:5 (2006), 1153–1159.
13. 13 Pritchard, A.L., Carroll, M.L., Burel, J.G., White, O.J., Phipps, S., Upham, J.W., Innate IFNs and plasmacytoid dendritic cells constrain Th2 cytokine responses to rhinovirus: a regulatory mechanism with relevance to asthma. J Immunol 188:12 (2012), 5898–5905.
14. 14 Dua, B., Watson, R.M., Gauvreau, G.M., O'Byrne, P.M., Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. J Allergy Clin Immunol 126:1 (2010), 133–139.
15. 15 McCarthy, N.E., Jones, H.A., Marks, N.A., et al. Inhaled allergen-driven CD1c up-regulation and enhanced antigen uptake by activated human respiratory-tract dendritic cells in atopic asthma. Clin Exp Allergy 37:1 (2007), 72–82.
16. 16 Brugha, R., Mushtaq, N., McCarthy, N.E., Stagg, A.J., Grigg, J., Respiratory tract dendritic cells in paediatric asthma. Clin Exp Allergy 45:3 (2015), 624–631.
17. 17 Cagnoni, E.F., Ferreira, D.S., Ferraz da Silva, L.F., et al. Bronchopulmonary lymph nodes and large airway cell trafficking in patients with fatal asthma. J Allergy Clin Immunol, 135(5), 2015 1352-1357.e1351-e1359.
18. 18 Dua, B., Tang, W., Watson, R., Gauvreau, G., O'Byrne, P.M., Myeloid dendritic cells type 2 after allergen inhalation in asthmatic subjects. Clin Exp Allergy 44:7 (2014), 921–929.
19. 19 El-Gammal, A., Oliveria, J.P., Howie, K., et al. Allergen-induced changes in bone marrow and airway dendritic cells in asthmatic subjects. Am J Respir Crit Care Med 194:2 (2016), 169–177.
20. 20 Scott, N.M., Ng, R.L., Gorman, S., Norval, M., Waithman, J., Hart, P.H., Prostaglandin E2 imprints a long-lasting effect on dendritic cell progenitors in the bone marrow. J Leukoc Biol 95:2 (2014), 225–232.
21. 21 Bleck, B., Kazeros, A., Bakal, K., et al. Coexpression of type 2 immune targets in sputum-derived epithelial and dendritic cells from asthmatic subjects. J Allergy Clin Immunol 136:3 (2015), 619–627.e615.
22. 22 Tworek, D., Smith, S.G., Salter, B.M., et al. Interleukin 25 receptor expression on airway dendritic cells after allergen challenge in asthmatic subjects. Am J Respir Crit Care Med 193:9 (2016), 957–964.
23. 23 Froidure, A., Shen, C., Gras, D., Van Snick, J., Chanez, P., Pilette, C., Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses. Allergy 69:8 (2014), 1068–1076.
24. 24 Schuijs, M.J., Willart, M.A., Vergote, K., et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349:6252 (2015), 1106–1110.
25. 25 Greer, A.M., Matthay, M.A., Kukreja, J., et al. Accumulation of BDCA1(+) dendritic cells in interstitial fibrotic lung diseases and Th2-high asthma. PloS One, 9(6), 2014, e99084.
26. 26 Froidure, A., Vandenplas, O., D'Alpaos, V., Evrard, G., Pilette, C., Persistence of asthma following allergen avoidance is associated with proTh2 myeloid dendritic cell activation. Thorax 70:10 (2015), 967–973.
27. 27 Yerkovich, S.T., Roponen, M., Smith, M.E., et al. Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response. J Allergy Clin Immunol 123:1 (2009), 209–216.e204.
28. 28 Yu, C.I., Becker, C., Metang, P., et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol 193:9 (2014), 4335–4343.
29. 29 Bratke, K., Lommatzsch, M., Julius, P., et al. Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax 62:2 (2007), 168–175.
30. 30 Spears, M., McSharry, C., Donnelly, I., et al. Peripheral blood dendritic cell subtypes are significantly elevated in subjects with asthma. Clin Exp Allergy 41:5 (2011), 665–672.
31. 31 Wright, A.K., Mistry, V., Richardson, M., et al. Toll-like receptor 9 dependent interferon-alpha release is impaired in severe asthma but is not associated with exacerbation frequency. Immunobiology 220:7 (2015), 859–864.
32. 32 Upham, J.W., Zhang, G., Rate, A., et al. Plasmacytoid dendritic cells during infancy are inversely associated with childhood respiratory tract infections and wheezing. J Allergy Clin Immunol 124:4 (2009), 707–713.e702.
33. 33 Edwards, M.R., Regamey, N., Vareille, M., et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol 6:4 (2013), 797–806.
34. 34 Simpson, J.L., Carroll, M., Yang, I.A., et al. Reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids. Chest 149:3 (2016), 704–713.
35. 35 Sykes, A., Edwards, M.R., Macintyre, J., et al. Rhinovirus 16-induced IFN-alpha and IFN-beta are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol 129:6 (2012), 1506–1514.e1506.
36. 36 Gill, M.A., Bajwa, G., George, T.A., et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol 184:11 (2010), 5999–6006.
37. 37 Durrani, S.R., Montville, D.J., Pratt, A.S., et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol 130:2 (2012), 489–495.
38. 38 Bratke, K., Nielsen, J., Manig, F., et al. Functional expression of granzyme B in human plasmacytoid dendritic cells: a role in allergic inflammation. Clin Exp Allergy 40:7 (2010), 1015–1024.
39. 39 Lommatzsch, M., Bratke, K., Knappe, T., et al. Acute effects of tobacco smoke on human airway dendritic cells in vivo. Eur Respir J 35:5 (2010), 1130–1136.
40. 40 Vassallo, R., Kroening, P.R., Parambil, J., Kita, H., Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses. Mol Immunol 45:12 (2008), 3321–3329.
41. 41 Mori, M., Andersson, C.K., Svedberg, K.A., et al. Appearance of remodelled and dendritic cell-rich alveolar-lymphoid interfaces provides a structural basis for increased alveolar antigen uptake in chronic obstructive pulmonary disease. Thorax 68:6 (2013), 521–531.
42. 42 Freeman, C.M., Martinez, F.J., Han, M.K., et al. Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180:12 (2009), 1179–1188.
43. 43 Demedts, I.K., Bracke, K.R., Van Pottelberge, G., et al. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175:10 (2007), 998–1005.
44. 44 Zanini, A., Spanevello, A., Baraldo, S., et al. Decreased maturation of dendritic cells in the central airways of COPD patients is associated with VEGF, TGF-beta and vascularity. Respiration 87:3 (2014), 234–242.
45. 45 Stoll, P., Heinz, A.S., Bratke, K., et al. Impact of smoking on dendritic cell phenotypes in the airway lumen of patients with COPD. Respir Res, 15, 2014, 48.
46. 46 Tsoumakidou, M., Tousa, S., Semitekolou, M., et al. Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand. J Allergy Clin Immunol 134:4 (2014), 944–954.e948.
47. 47 Larsen, J.M., Steen-Jensen, D.B., Laursen, J.M., et al. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PloS One, 7(2), 2012, e31976.
48. 48 Dreschler, K., Bratke, K., Petermann, S., et al. Altered phenotype of blood dendritic cells in patients with acute pneumonia. Respiration 83:3 (2012), 209–217.
49. 49 Lichtner, M., Mastroianni, C.M., Rossi, R., et al. Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection. PloS One, 6(5), 2011, e19872.
50. 50 Thomas, A., Hassan, R., Immunotherapies for non-small-cell lung cancer and mesothelioma. Lancet Oncol 13:7 (2012), e301–e310.
51. 51 Goc, J., Germain, C., Vo-Bourgais, T.K., et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res 74:3 (2014), 705–715.
52. 52 Mu, C.Y., Huang, J.A., Chen, Y., Chen, C., Zhang, X.G., High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Med Oncol 28:3 (2011), 682–688.
53. 53 Schneider, T., Hoffmann, H., Dienemann, H., et al. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3. J Thor Oncol 6:7 (2011), 1162–1168.
54. 54 Kuo, P.L., Huang, M.S., Cheng, D.E., Hung, J.Y., Yang, C.J., Chou, S.H., Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor. J Biol Chem 287:13 (2012), 9753–9764.
55. 55 Kimura, H., Matsui, Y., Ishikawa, A., Nakajima, T., Yoshino, M., Sakairi, Y., Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer. Cancer Immunol Immunother 64:1 (2015), 51–59.
56. 56 Radford, K.J., Caminschi, I., New generation of dendritic cell vaccines. Hum Vaccin Immunother 9:2 (2013), 259–264.